Location: /Project/UoS/Sites/UoS/Research/RIMHS/Research Stories/
the Pharmacy Research and Evidence Translation Award | 2nd EPS Conference 2026
Organization Name: Emirates Pharmacy Society
Award Name: Pharmacy Excellence Award
Award Category: Pharmacy Research and Evidence Translation
Won Rank: First Place
Website: https://eps-uae.org/2nd-emirates-pharmacy-society-conference/
Award Description:
Aim: Recognizes pharmacists who have made significant contributions to pharmaceutical sciences, clinical research, and academia.
Selection Criteria:
- Pharmacist, academic, or researcher affiliated with a UAE institution or internationally.
- Hold a postgraduate academic qualification (Master’s degree or PhD).
- Published research related to pharmacy practice or pharmaceutical sciences within the last 3 years.
- Demonstrate how their work has influenced at least one of the following:
- Clinical practice
- Clinical guidelines or standards of care
- Pharmacy education and training
- Healthcare policy or decision-making
- Patient outcomes
- Quality improvement initiatives
Professor Mark Rawas Translational Research Contribution:
Prof. Mark contribution for the award competition included the research completed for the following projects:
- Development of a non-invasive novel dosage form for the emergency treatment of anaphylaxis as an alternative to epinephrine auto-injectors (EpiPen)
- Development of a user-friendly novel antidote for the treatment of organophosphates poisoning
The outcomes have been disseminated in the form of patents and peer-reviewed articles, as follows:
Patents
- Japanese Patent Pub (JPO) # JP7657457 B2. Granted Apr 7, 2025. (Issued Patent).
- US Patent Pub (USPTO) # US 12,337,063 B2. Granted June 24, 2025. (Issued Patent)
- US Patent Pub (USPTO) # US 12,357,591 B1. Granted Jul 15, 2025. (Issued Patent)
- Australian Patent Pub (APO) # AU2019361136 B2. Granted Aug 8, 2025. (Issued Patent)
- European Patent Pub (EPO) # EP3866774 B1. Granted Jan 28, 2026. (Issued Patent)
- Spain Patent Pub (OEPM) # ES3070125 T3. Granted Jan 28, 2026. (Issued Patent).
- US Patent Pub (USPTO) # US20260007619 A1. Published Jan 8, 2026. (Pending Patent).
Peer-Reviewed Publications
- Debe MS, Khan SA, Ahmed IS, Hussain Z, Uddin MN, Rawas-Qalaji M*. Nasal Versus Sublingual Routes for Emergency Drug Administration. Journal of Pharmaceutical Sciences. 2025; 114(9):103903. DOI: https://doi.org/10.1016/j.xphs.2025.103903
- Rawas-Qalaji M*, Alozi M, Khan SA, Hussain Z, Ahmed IS. Sublingual Route for the Continuous Release of Epinephrine from Chitosan Nanoparticles. Journal of Drug Delivery Science and Technology. 2024;101 (Part B): 106246. DOI: https://doi.org/10.1016/j.jddst.2024.106246.
- Rawas-Qalaji M*, Cagliani R, Al-Hashimi N, Al-Dabbagh R, Al-Dabbagh A, Hussain Z. Microfluidics in drug delivery: review of methods and applications. Pharm Dev Technol. 2023;28(1):61-77. DOI: https://doi.org/10.1080/10837450.2022.2162543.
- Rawas-Qalaji M*, Thu HE, Hussain Z. Oromucosal delivery of macromolecules: Challenges and recent developments to improve bioavailability. Int J Pharm. 2022;352: 726-746. DOI: https://doi.org/10.1016/j.jconrel.2022.10.059.
- Ola Asaad Al-Abboodi, Mutasem Rawas-Qalaji*, Zahid Hussain. A Review of Patents in the Field of Microfluidics. In Dimitrios A. Lamprou, Edward Weaver (Eds). Microfluidics in Pharmaceutical Sciences: Formulation, Drug Delivery, Screening, and Diagnostics. Springer; 2024: 421-452. ISBN: 978-3-031-60716-5. DOI: https://doi.org/10.1007/978-3-031-60717-2.
Event:
Emirates Pharmacy Society invited scientists to apply for this award based on the above criteria.
The Award Committee screened applications and contacted the top three candidates to present their achievements on the first day of the 2nd Emirates Pharmacy Society Conference (Sep 12-13, 2026, hosted at Sofitel Dubai The Obelisk).
The Award Committee announced the winner on the second day of the conference.
